CD8A and cancer: The aforementioned CD274 (PD-L1) is widely known for its key role in the immunosuppressive tumor microenvironment and is a target for cancer therapies (together with PD-L1 receptor, PD-1), which can cause colitis through the activation of resident memory CD8+ T cells [30].